OC-0504 Randomized phase 2 trial of adaptive dose painting vs. standard IMRT for head and neck cancer.

Radiotherapy and Oncology ◽

10.1016/s0167-8140(19)30924-7 ◽

2019 ◽

Vol 133 ◽

pp. S259-S260 ◽

Author(s):

F. Duprez ◽

J. Daisne ◽

D. Berwouts ◽

W. De Gersem ◽

I. Goethals ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Neck Cancer ◽

Phase 2 ◽

Dose Painting ◽

Phase 2 Trial ◽

Randomized Phase 2

Download Full-text

Updated Results From a Phase 1/Randomized Phase 2 Trial of Response-Adapted Volume De-escalation (RAVD) for Locally Advanced Head and Neck Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2016.06.544 ◽

2016 ◽

Vol 96 (2) ◽

pp. S219

Author(s):

J.M. Melotek ◽

V.M. Villaflor ◽

T.G. Karrison ◽

R.J. Brisson ◽

E.A. Blair ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Neck Cancer ◽

Phase 1 ◽

Locally Advanced ◽

Advanced Head ◽

Phase 2 ◽

Phase 2 Trial ◽

Randomized Phase 2

Download Full-text

Randomized Phase 2 Trial of a Novel Clonidine Mucoadhesive Buccal Tablet for the Amelioration of Oral Mucositis in Patients Treated With Concomitant Chemoradiation Therapy for Head and Neck Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2019.10.023 ◽

2020 ◽

Vol 106 (2) ◽

pp. 320-328 ◽

Author(s):

Jordi Giralt ◽

Yungan Tao ◽

Rolf-Dieter Kortmann ◽

Xavier Zasadny ◽

Jorge Contreras-Martinez ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Neck Cancer ◽

Oral Mucositis ◽

Chemoradiation Therapy ◽

Phase 2 ◽

Phase 2 Trial ◽

Buccal Tablet ◽

Concomitant Chemoradiation ◽

Randomized Phase 2

Download Full-text

Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2016.04.030 ◽

2016 ◽

Vol 96 (1) ◽

pp. 21-29 ◽

Author(s):

Tanguy Y. Seiwert ◽

James M. Melotek ◽

Elizabeth A. Blair ◽

Kerstin M. Stenson ◽

Joseph K. Salama ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Induction Chemotherapy ◽

Neck Cancer ◽

Advanced Head ◽

Phase 2 ◽

Phase 2 Trial ◽

Randomized Phase 2

Download Full-text

Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation Therapy for Locoregionally Advanced Head and Neck Cancer: HPV-negative Subset Analysis

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2015.12.029 ◽

2016 ◽

Vol 94 (4) ◽

pp. 867

Author(s):

J.M. Melotek ◽

D.J. Haraf ◽

E.A. Blair ◽

M.E. Witt ◽

R.J. Brisson ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Induction Chemotherapy ◽

Neck Cancer ◽

Chemoradiation Therapy ◽

Advanced Head ◽

Phase 2 ◽

Subset Analysis ◽

Phase 2 Trial ◽

Randomized Phase 2

Download Full-text

Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer

Cancer ◽

10.1002/cncr.24525 ◽

2009 ◽

Vol 115 (19) ◽

pp. 4514-4523 ◽

Author(s):

Robert Haddad ◽

Stephen Sonis ◽

Marshall Posner ◽

Lori Wirth ◽

Rosemary Costello ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Neck Cancer ◽

Locally Advanced ◽

Advanced Head ◽

Phase 2 ◽

Concomitant Chemoradiotherapy ◽

Phase 2 Study ◽

Randomized Phase 2

Download Full-text

A priori quality assurance using a benchmark case of the randomized phase 2 GORTEC 2014-14 in oligometastatic head and neck cancer patients

Cancer/Radiothérapie ◽

10.1016/j.canrad.2021.04.005 ◽

2021 ◽

Author(s):

N. Khalladi ◽

C. Dejean ◽

M. Bosset ◽

Y. Pointreau ◽

R. Kinj ◽

...

Keyword(s):

Quality Assurance ◽

Head And Neck Cancer ◽

Head And Neck ◽

Cancer Patients ◽

Neck Cancer ◽

A Priori ◽

Phase 2 ◽

Randomized Phase 2

Download Full-text

A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab‐resistant head and neck cancer: The MAESTRO study

Cancer ◽

10.1002/cncr.32929 ◽

2020 ◽

Vol 126 (14) ◽

pp. 3237-3243 ◽

Author(s):

Tanguy Y. Seiwert ◽

Sara Kochanny ◽

Kevin Wood ◽

Francis P. Worden ◽

Douglas Adkins ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Neck Cancer ◽

Phase 2 ◽

Phase 2 Study ◽

Randomized Phase 2

Download Full-text

Nanoparticle albumin-bound paclitaxel with cetuximab and carboplatin as first-line therapy for recurrent or metastatic head and neck cancer: A single-arm, multicenter, phase 2 trial

Oral Oncology ◽

10.1016/j.oraloncology.2020.105173 ◽

2021 ◽

Vol 115 ◽

pp. 105173

Author(s):

Douglas Adkins ◽

Jessica Ley ◽

Omar Atiq ◽

Steven Powell ◽

William C. Spanos ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Neck Cancer ◽

Phase 2 ◽

First Line Therapy ◽

Phase 2 Trial ◽

Multicenter Phase ◽

Download Full-text

P016 Oxaliplatin, Folinic Acid, and 5-Fluorouracil (OFF) in Recurrent Advanced Head and Neck Cancer: A Phase 2 Trial

Archives of Otolaryngology - Head and Neck Surgery ◽

10.1001/archotol.132.8.869-b ◽

2006 ◽

Vol 132 (8) ◽

pp. 869

Author(s):

J. D. Raguse ◽

J. Bier ◽

H. Oettle

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Folinic Acid ◽

Neck Cancer ◽

Advanced Head ◽

Phase 2 ◽

Download Full-text

Phase 2 trial of concurrent 5-fluorouracil, hydroxyurea, cetuximab, and hyperfractionated intensity-modulated radiation therapy for locally advanced head and neck cancer

Cancer ◽

10.1002/cncr.25374 ◽

2010 ◽

Vol 117 (2) ◽

pp. 318-326 ◽

Author(s):

Johnny Kao ◽

Eric M. Genden ◽

Vishal Gupta ◽

Edelweiss L. Policarpio ◽

Ryan J. Burri ◽

...

Keyword(s):

Radiation Therapy ◽

Head And Neck Cancer ◽

Head And Neck ◽

Neck Cancer ◽

Locally Advanced ◽

Intensity Modulated Radiation Therapy ◽

Advanced Head ◽

Phase 2 ◽

Intensity Modulated ◽

Download Full-text